# Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva

> **NCT00395499** · — · COMPLETED · sponsor: **Ohio State University** · enrollment: 19 (—)

## Conditions studied

- Patients Already Taking Risperidone for Clinical Indications

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00395499
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 19 (—)
- **Last updated:** 2016-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395499, "Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00395499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*